Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
Other Long-Term Assets
Modalis Therapeutics Corp
Other Long-Term Assets Peer Comparison
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Modalis Therapeutics Corp
TSE:4883
|
Other Long-Term Assets
¥69.6m
|
CAGR 3-Years
86%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Other Long-Term Assets
¥286.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
47%
|
|
PeptiDream Inc
TSE:4587
|
Other Long-Term Assets
¥2.4B
|
CAGR 3-Years
67%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Other Long-Term Assets
¥1.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Other Long-Term Assets
¥36.1m
|
CAGR 3-Years
131%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
14%
|
S
|
StemRIM Inc
TSE:4599
|
Other Long-Term Assets
¥38.3m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Other Long-Term Assets?
Other Long-Term Assets
69.6m
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Other Long-Term Assets amounts to 69.6m JPY.
What is Modalis Therapeutics Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
51%
Over the last year, the Other Long-Term Assets growth was 1%. The average annual Other Long-Term Assets growth rates for Modalis Therapeutics Corp have been 86% over the past three years , 51% over the past five years .